Ms. Patricia Janel Meredith, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2440 Century Place Se, Hickory Va Cboc, Hickory, NC 28602 Phone: 828-431-5600 Fax: 828-431-5637 |
Sylvia Tobiasz Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 422 5th St Se, Hickory, NC 28602 Phone: 828-308-1969 |
Mrs. Cherie Peyton Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1170 Fairgrove Church Rd, Hickory, NC 28602 Phone: 828-464-1172 |
Runy L Thao, MSW, LCSW-A Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5146 Morrison Dr, Hickory, NC 28602 Phone: 828-228-0598 |
Savannah Aldridge Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1940 3rd Avenue Ln Se, Hickory, NC 28602 Phone: 704-864-1477 Fax: 704-396-7524 |
Tiffany Nunez, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 179 28th Ave Ne, Hickory, NC 28601 Phone: 828-777-5565 |
Jennifer Dierker, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1985 Tate Blvd Se, Suite 300, Hickory, NC 28602 Phone: 828-326-5960 Fax: 828-328-4729 |
News Archive
Patients rehospitalized with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation compared to those readmitted to a different hospital, according to a national study involving over 9 million Medicare patients in the USA, published in The Lancet.
Wenzel Spine, Inc., a medical device company focused on providing less invasive, stand-alone alternatives to traditional spinal fusion, today announced that it has successfully surpassed the 26,000th implantation of its Stand-Alone VariLift Expandable Interbody Fusion Device.
OIST researchers develop a simple printing method to create effective disease detection tools.The field of medicine is always on the lookout for better disease diagnostic tools—simpler, faster, and cheaper technologies to enhance patient treatment and outcomes.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
› Verified 9 days ago